PEDIATRIC ONCOLOGY GROUP

介绍了儿科合作癌症小组的概念。 30年前，由于儿科恶性疾病的罕见和 对照试验对改善此类试验的结果至关重要 病人。要想让这样一个团体取得成功， 来自各种专业和研究领域的个人 绝对必要。这种多模式有组织的治疗方法 儿童癌症的合作小组已经很好地展示了它的 价值。贝勒医学院儿科血液肿瘤科 医学已经参与了这种临床研究的起源。 并参加了各级活动。这是意料之中的 在下一个赠款期间，这种情况将继续并增加。 初步调查正在进行中，希望能提供 儿科肿瘤学小组未来工作的背景。

The concept of the pediatric cooperative cancer group was introduced over 30 years ago, because of the rarity of pediatric malignant diseases and the vital importance of controlled trials to improve the outcome for such patients. For such a group to succeed, the collaborative contributions of individuals from a large variety of specialties and fields of research are absolutely essential. This multimodal organized approach to the treatment of childhood cancer through the cooperative group has well-demonstrated its value. The Section of Pediatric Hematology-Oncology at Baylor College of Medicine has been involved in the genesis of this kind of clinical research and has participated in the activities at every level. It is anticipated that this will continue and increase during the next grant period. Preliminary investigators are ongoing which hopefully will provide background for future Pediatric Oncology Group efforts.